Medpace Holdings, Inc.

MEDPNasdaq· Services-Commercial Physical & Biological Research

Price History

Revenue

$2.5B

▲ 20.0% YoY

Net Income

$451.1M

▲ 11.6% YoY

EPS

$15.28

▲ 21.0% YoY

Cash

$497.0M

▼ 25.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.